(Q36935185)

17 August 2017

Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate (English)

1 reference

17 August 2017

Uta Lichter-Konecki

1

1 reference

17 August 2017

G A Diaz

2

1 reference

17 August 2017

J L Merritt

3

1 reference

17 August 2017

A Feigenbaum

4

1 reference

17 August 2017

C Jomphe

5

1 reference

17 August 2017

J F Marier

6

1 reference

17 August 2017

M Beliveau

7

1 reference

17 August 2017

J Mauney

8

1 reference

17 August 2017

K Dickinson

9

1 reference

17 August 2017

A Martinez

10

1 reference

17 August 2017

M Mokhtarani

11

1 reference

17 August 2017

B Scharschmidt

12

1 reference

17 August 2017

W Rhead

13

1 reference

17 August 2017

5 May 2011

1 reference

Molecular Genetics and Metabolism

17 August 2017

1 reference

17 August 2017

103

1 reference

17 August 2017

4

1 reference

17 August 2017

323-329

1 reference

Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Cross-sectional multicenter study of patients with urea cycle disorders in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Urea cycle disorders: diagnosis, pathophysiology, and therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880058

Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.04.013

Phase I study of phenylacetate administered twice daily to patients with cancer

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.04.013

10.1016/J.YMGME.2011.04.013

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

21612962

1 reference